Summary : In just two short years, BioNTech will have more than doubled the size of its workforce at the German biologics…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Tag:
Pharmanews
-
-
Summary : Beckley Psytech leads a new project focused on addressing psychiatric and neurological conditions through the use of psychedelic medicines. As interest…
-
AgrochemicalsGlobal Market
Enrol call: Verona recruits 800 patients for COPD trial
by adminby adminSummary : The phase 3 trial involved over 800 candidates to assess ensifentrine when administered as a maintenance therapy to patients diagnosed…
-
Chennai: The city-based laboratory says it has developed an RT-PCR test kit that can detect the Covid-19 virus in 45 minutes and…
-
AgrochemicalsGlobal MarketPharma Science & Research
NIH awards $170 million for Precision Nutrition Study
by adminby adminSynopsis : The National Institutes of Health (NIH) is awarding $170 million over five years, pending the availability of funds, to clinics…
-
AgrochemicalsGlobal Market
Oncolytics Biotech provides enrollment update on multi-indication phase 1/2 gastrointestinal cancer trial at 2022 ASCO-GI symposium
by adminby adminSummary : Successfully enrolled first-line metastatic pancreatic and third-line metastatic colorectal safety run-ins Company moving to full enrollment pending independent safety review…
-
Pharma Science & Research
An estimated 1.2 million people died in 2019 from antibiotic-resistant bacterial infections
by adminby adminSummary : More than 1.2 million people – and potentially millions more – died in 2019 as a direct result of antibiotic-resistant…
-
Summary : Psyros Diagnostics has signed an agreement to be acquired by the Swedish company, Prolight Diagnostics AB. Psyros’s ground-breaking Point-of-Care (POC)…
-
AgrochemicalsBristol Myers Squibb
Fierce JPM Week: Bristol Myers’ next-gen autoimmune med not just another JAK drug, exec says
by adminby adminSummary : After a high-profile study turned up safety risks for Pfizer’s JAK inhibitor Xeljanz last year, the FDA put the entire…
-
Synopsis : Today, the U.S. Food and Drug Administration approved Nexviazyme (avalglucosidase alfa-ngpt) for intravenous infusion to treat patients 1 year of…